Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael


Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles


Have $3,000? Buying These 2 Stocks Would Be the Smartest Move You Ever Made

Both companies are using nanotechnology to revolutionize healthcare and manufacturing. Plus, they have considerable upside.


Up 938% in 2020, Is Co-Diagnostics Still a Buy in 2021?

This diagnostic specialist started off the year as a micro cap, but it roared ahead with its COVID-19 test.


Activision Blizzard: Buy or Sell?

It's possible that Wall Street has the wrong idea about what kind of company this video game publisher really is.

Why_the_Market_Is_So_Bullish_About_Trillium_Therapeutics (1)

Why the Market Is So Bullish About Trillium Therapeutics

The cancer biotech soared in 2020, jumping up over 1,000% for the year. What will the stock do in 2021?


After Its 1,500% Jump, Is It Time to Sell Vaxart Stock?

After the stock's magnificent run in 2020, it might be time to take profits.


Why the No. 1 Healthcare Stock of 2020 Is Still a Buy

Novavax has significant upside if its phase 3 data are positive.


Is It Too Late to Get In On This Millionaire-Making Stock?

While it's already made some people rich, Axsome Therapeutics is just getting started.


Top 5 Healthcare Stocks of 2020: Are They Buys Now?

These five winners in the healthcare space were all micro-caps at the beginning of the year. How big can they get?


If You Invested $10,000 in Personalis in the Coronavirus Crash, This Is How Much You'd Have Now

Investors weren't very happy when shares tanked in March, but have been smiling ever since.


Why I'm Not Buying Vaxart Stock

There are some warning signs around this vaccine-maker that investors should take seriously.


Ubisoft Joins With Disney to Develop New 'Star Wars' Game

Now Ubisoft is hard at work on two Disney properties with massive upside: "Star Wars" and "Avatar."


Will IMAX Keep Losing in 2021?

The stock dropped 13% in 2020. Will it recover this year?


The 10 Best-Performing Stocks of 2020

Biotech, bitcoin, and renewable energy led the way.


My 2 Top Small-Cap Stocks to Own In 2021

Silvergate Capital and Ontrak have massive runways for growth in the new year.


Here's Why You Should Really Own DermTech Stock in 2021

The biotech's skin cancer diagnostic tool is a significant improvement over the standard of care.


This Stock Could Be a Surprise Growth Pick for 2021

Down 77% in 2020, Amarin's stock should zoom higher once Vascepa obtains European approval.


Investors in This One Stock Had an Amazing Year

Novavax had the highest returns of any stock on the market in 2020.


Here's a Cancer-Killing Stock to Buy for 2021

"Natural killer" (or NK) cancer therapies are hot right now. Here are two stocks that are early leaders in the field -- one is a buy, and the other one is not.


Why Is Everybody Talking About Novavax Stock?

Its coronavirus vaccine could make it an even bigger winner.


Why Peter Lynch Would Love Freshpet Stock

This dog food stock has been an incredible 16-bagger over the last five years.